Evidence map›Paper›PMID 34653523›Full record

ReviewJournal of molecular and cellular cardiology2022

Krüppel-like factor (KLF)5: An emerging foe of cardiovascular health.

Dimitra Palioura, Antigone Lazou, Konstantinos Drosatos

Open access · greenAbstract readReview
In one paragraph

Review in Journal of molecular and cellular cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Ythdc1-p300-Klf5 Complex-Mediated Golgi Dysfunction Promotes Aortic Aneurysm.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. The miRNomics of antiretroviral therapy-induced obesity.Functional & integrative genomics · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Dimitra PaliouraCenter for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA; School of Biology, Aristotle University of Thessaloniki, GR, Greece.
Antigone LazouSchool of Biology, Aristotle University of Thessaloniki, GR, Greece.
Konstantinos DrosatosCenter for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA. Electronic address: drosatos@temple.edu.
Temple University · USAristotle University of Thessaloniki · GR

Funding

Role of KLF5 in cardiac and systemic fatty acid metabolismR01HL130218 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI DROSATOS, KONSTANTINOS · 2016 to 2020
$1.9M
Role of cardiomyocyte KLF5 in heart failure.R01HL151924 · NHLBI · UNIVERSITY OF CINCINNATI · PI DROSATOS, KONSTANTINOS · 2020 to 2023
$1.9M
Role of JNK and BNP in Septic HypotensionR01GM135399 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI DROSATOS, KONSTANTINOS, GENTILE, NINA T · 2020 to 2021
$809k
NHLBI NIH HHS R01 HL130218NHLBI NIH HHS R01 HL151924NIGMS NIH HHS R01 GM135399
6 · The paper itself

Abstract

Krüppel-like factors (KLFs) are DNA-binding transcriptional factors, which regulate various pathways that pertain to development, metabolism and other cellular mechanisms. KLF5 was first cloned in 1993 and by 1999, it was reported as the intestinal-enriched KLF. Beyond findings that have associated KLF5 with normal development and cancer, it has been associated with various types of cardiovascular (CV) complications and regulation of metabolic pathways in the liver, heart, adipose tissue and skeletal muscle. Specifically, increased KLF5 expression has been linked with cardiomyopathy in diabetes, end-stage heart failure, and as well as in vascular atherosclerotic lesions. In this review article, we summarize research findings about transcriptional, post-transcriptional and post-translational regulation of KLF5, as well as the role of KLF5 in the biology of cells and organs that affect cardiovascular health either directly or indirectly. Finally, we propose KLF5 inhibition as an emerging approach for cardiovascular therapeutics.

Indexed as

CardiomyopathiesCardiovascular SystemHeartHumansKruppel-Like Transcription FactorsTranscription FactorsKLF5 protein, humanKruppel-Like Transcription FactorsTranscription FactorsAtherosclerosisCardiovascular physiologyEnergy metabolismHeart failureKrüppel-like factor 5

Identifiers

PMID34653523
PMCPMC8816822
OpenAlexW3206381662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.